- Home
- Labeler Index
- Boehringer Ingelheim Pharmaceuticals, Inc.
- 0597-0164
- NDC Crossover: 0597-0164 Glyxambi
NDC Crossover 0597-0164 Glyxambi
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Empagliflozin; Linagliptin
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 0597-0164 – Glyxambi, a human prescription drug. This list includes other cross-matching products that share:
- The same product name: Glyxambi
- OR Generic name: Empagliflozin And Linagliptin
- AND the same Administration Route: oral
- OR Dosage Form: tablet, film coated
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 0597-0182 | Glyxambi | Empagliflozin And Linagliptin | Tablet, Film Coated | Oral | Boehringer Ingelheim Pharmaceuticals, Inc. | Human Prescription Drug |
